Introduction
============

In the Philippines, cardiovascular diseases remain the leading cause of mortality.[@suz066-B1] Hypertension is the biggest contributor to the global burden of disease and to global mortality, accounting for around 10.5 million deaths worldwide annually.[@suz066-B2]^,^[@suz066-B3]

The prevalence of hypertension in the Philippines has steadily increased in the past two decades, as shown in the national health surveys.[@suz066-B4]^,^[@suz066-B5] The National Nutrition and Health Survey in 2013 (NNHeS 2013) reported a prevalence of 25%.[@suz066-B4] Another local survey conducted by the Philippine Heart Association showed that though there was an improved awareness compared to previous surveys of 76%, only 20% have achieved blood pressure (BP) control.[@suz066-B5] This highlights the need for opportunistic BP screening to diagnose unaware individuals with raised BP and those who are aware but inadequately treated.

The Philippine Society of Hypertension (PSH) joined May Measurement Month (MMM)---a global month-long awareness and screening campaign initiated by the International Society of Hypertension (ISH) to raise awareness on hypertension, and draw attention to the need for more screening programs.[@suz066-B6]^,^[@suz066-B7]

Methods
=======

The Philippines was one of 80 countries worldwide that took part in MMM17, using the protocol designed by the ISH. With MMM17 being a laudable global initiative, the ethical clearance requirement was generally waived by the participating institutions. There were over 300 sites nationwide---in the communities, hospitals, pharmacies, schools and existing clinics of individual doctor volunteers---including 169 DOH *Barangay* (community) health centres, as well as other sites manned by volunteers and partner organizations of the PSH. Training for the volunteers was done via video recordings, with face-to-face training done for volunteers whenever feasible. Aside from the ISH and PSH, a major funding source was LRI-Therapharma, a local pharmaceutical company with a strong advocacy for raising BP awareness. The company undertook the screening in major industrial outlets such as big offices and factories nationwide. Omron Global Healthcare, through its Asia-Pacific Division, donated 3000 digital automatic, upper-arm BP devices.

After kick-off in the presence of eminent politicians, the screening lasted for 38 days, although there were days during the month when it had to be interrupted due to inclement weather or some national security concerns. Heavy multi-media promotions were done, with major mainstream print/digital media, television and radio being very supportive.

Most of the measurements were done using the Omron devices, although a small number used other types of digital device or an aneroid sphygmomanometer. Only a small number used the App developed specifically for MMM17 because of the unavailability of internet in most sites. Data recorded on paper forms were manually transferred to excel spreadsheets by 15 encoders under the supervision of the PSH secretariat. A cursory screening of the data was done locally, but most of the data 'cleaning' and analysis was done centrally by the MMM statistical team.[@suz066-B7] Multiple imputation was used to impute the mean of the second and third readings where it was not available. Hypertension was defined as systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or on antihypertensive treatment.

Results
=======

A total of 271 604 participants' data were submitted from the various Philippine sites, comprising 22.6% of the global pooled data of 1 201 570 screened individuals.[@suz066-B7] Mean age of participants was 42.6 years with more females (61.1%) than males (37.9%). The majority of the participants were of East Asian descent (77%) with 19% of unknown ethnicity, and 4.3% were South Asians. Out of the total participants, 16 729 (6.2%) had diabetes, 3684 (1.4%) a history of myocardial infarction (MI); and 7015 (2.6%) a history of stroke. 32 995 (12.2%) were current smokers and 27 099 (10%) reported intake of alcohol, once or more per week. The mean body mass index (BMI) of participants was 23.9 kg/m^2^ (SD 4). A small proportion of women were pregnant (0.3%).

Out of the 205 041 participants with three readings, the BP decreased on average by 2/0.9 mmHg between the first and third readings (*Table [1](#suz066-T1){ref-type="table"}*).

###### 

Differences in mean blood pressure

                             Reading 1   Reading 2   Reading 3   Mean readings 1 and 2   Mean readings 2 and 3
  -------------------------- ----------- ----------- ----------- ----------------------- -----------------------
  Mean systolic BP (mmHg)    121.1       119.7       119.0       120.5                   119.4
  Mean diastolic BP (mmHg)   78.8        78.2        77.9        78.6                    78.2

Based on 205 041 participants with all three readings
=====================================================

After imputation, out of 268 490 participants, 91 994 (34.3%) were hypertensive. There were 28 662 out of 205 158 participants (14.0%) that were not receiving treatment who were found to have hypertension. Of the 60 370 participants reporting that they were receiving treatment, 25 144 (41.6%) had uncontrolled BP.

After adjusting for age and sex, BPs were significantly higher for those participants receiving antihypertensive medication and those with previous MI or stroke. Lower BP measurements were noted when taken on the left arm, and in pregnant women ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *[Figure S1](#sup1){ref-type="supplementary-material"}*). Conversely, a slightly higher SBP was noted in participants who reported no alcohol intake (never or rarely) compared to those who took one or more drinks weekly. The obese (BMI ≥ 30) and overweight (BMI ≥ 25 and \<30) also had significantly higher BPs ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *[Figure S2](#sup1){ref-type="supplementary-material"}*). The BP readings also varied during the week, with the highest BPs recorded during the weekends (Saturday and Sunday) and the lowest readings obtained on Tuesdays ([Supplementary material online](#sup1){ref-type="supplementary-material"}, *[Figure S3](#sup1){ref-type="supplementary-material"}*).

Discussion
==========

In this cross-sectional survey, over one-third was found to be hypertensive. Out of the 60 370 participants reporting that they were receiving treatment, 25 144 (41.6%) still had inadequately controlled BP. The figures are similar to what were reported in previous national surveys,[@suz066-B4]^,^[@suz066-B5] showing that a quarter to a third of hypertensive Filipinos do not know that they have elevated BP and less than half of those who are receiving antihypertensive treatment are adequately controlled. This highlights the need for a sustained screening program to diagnose individuals with elevated BP, particularly those who are at risk to develop serious cardiovascular complications. It was also noted in this survey that those with previous MI and stroke still had generally higher BP than their lower-risk counterparts. Such high-risk individuals can be identified also in surveys like this, and referred back to their respective physicians for a more aggressive control of their BP.

With all volunteers working *pro bono*, the local logistical cost in implementing MMM17 was only around USD 0.31 per participant screened, with one-third of them diagnosed to have elevated BP. This makes the MMM campaign an ideal stopgap solution to the lack of screening programs in the country and worldwide.

There appeared to be a linear correlation between the BPs obtained in this screening and the weight, with obese participants having the highest level of BP compared to those with normal weight or underweight. Current smokers likewise had higher BPs than non-smokers, which was contrary to what was observed in a recent survey in another Asian country.[@suz066-B8] The BP readings appeared to be highest during the weekends particularly Sunday with the lowest BP readings on Tuesday. This may be due to a presumably increased exposure to adverse lifestyle factors during weekends---starting from the Thank God it's Friday evenings---that may exert a contributory pressor effect.[@suz066-B7] This transient effect may dissipate with the resumption of the work week; hence, the relatively low BP readings on Tuesday. Such a pattern of BP behaviour requires further investigation.

Conclusions and implications
============================

Opportunistic BP screening and sustained public awareness and screening campaigns harnessing volunteers appear to be a cost-effective public health measure to improve awareness and treatment rates of raised BP. Analysis of local data may provide medical practitioners and health officials a better understanding of the profile of their hypertensive population, and guide them in drafting preventive and therapeutic measures to improve treatment and control rates, and long-term outcomes of hypertensive individuals in the population.

Supplementary Material
======================

###### 

Click here for additional data file.
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